Open | $0.960 |
Close | $0.980 |
Volume / Avg. | 176.417K / 302.550K |
Day Range | 0.960 - 1.019 |
52 Wk Range | 0.500 - 12.270 |
Market Cap | $4.528M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 1.44% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Phio Pharma (NASDAQ: PHIO) through any online brokerage.
Other companies in Phio Pharma’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).
The latest price target for Phio Pharma (NASDAQ: PHIO) was reported by HC Wainwright & Co. on Tuesday, February 6, 2024. The analyst firm set a price target for 4.00 expecting PHIO to rise to within 12 months (a possible 304.08% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Phio Pharma (NASDAQ: PHIO) is $0.9899 last updated March 18, 2024 at 7:39 PM EDT.
There are no upcoming dividends for Phio Pharma.
Phio Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Phio Pharma.
Phio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.